Tech Company Financing Transactions

Escoublac Funding Round

Escoublac, based in Cambridge, raised $6.7 million from private investors.

Transaction Overview

Company Name
Announced On
1/10/2008
Transaction Type
Venture Equity
Amount
$6,650,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
14 Cambridge Center
Cambridge, MA 02142
USA
Email Address
Overview
Escoublac was established based on the discovery that osteocalcin, a protein found in bone and dentin, plays a role in energy metabolism and related disorders.The company aims to transform this discovery into new therapies for metabolic disorders and related conditions, such as obesity and type 2 diabetes.
Profile
Escoublac LinkedIn Company Profile
Social Media
Escoublac Company Twitter Account
Company News
Escoublac News
Facebook
Escoublac on Facebook
YouTube
Escoublac on YouTube

Management Team

Title
Name
Email & Social
Chief Scientific Officer
Nils Bergenhem
  Nils Bergenhem LinkedIn Profile  Nils Bergenhem Twitter Account  Nils Bergenhem News  Nils Bergenhem on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/10/2008: Outspark venture capital transaction
Next: 1/10/2008: XLerant venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary